share_log

Altimmune | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TIAA-CREF Investment Management, LLC(2.88%),Teachers Advisors, LLC(0.32%), etc.

SEC announcement ·  Feb 14 12:07
Summary by Moomoo AI
On December 31, 2023, Altimmune, Inc., a biopharmaceutical company, was the subject of a Schedule 13G filing with the Securities and Exchange Commission (SEC), indicating changes in ownership by significant investors. The filing, dated February 14, 2024, reports that Nuveen Asset Management, LLC (NAM), TIAA-CREF Investment Management, LLC (TCIM), and Teachers Advisors, LLC (TAL), all based in Delaware, have updated their holdings in Altimmune's common stock. NAM reported ownership of 6,679 shares, TCIM reported 1,549,364 shares, and TAL reported 171,273 shares. Collectively, these holdings represent a total of 3.21% of the company's common stock. The filing specifies that these shares were acquired in the ordinary course of business and not with the intention of changing or influencing the control of Altimmune. The filing was made in accordance with Rule 13d-1(b) of the Securities Exchange Act of 1934, which applies to certain institutional investment managers.
On December 31, 2023, Altimmune, Inc., a biopharmaceutical company, was the subject of a Schedule 13G filing with the Securities and Exchange Commission (SEC), indicating changes in ownership by significant investors. The filing, dated February 14, 2024, reports that Nuveen Asset Management, LLC (NAM), TIAA-CREF Investment Management, LLC (TCIM), and Teachers Advisors, LLC (TAL), all based in Delaware, have updated their holdings in Altimmune's common stock. NAM reported ownership of 6,679 shares, TCIM reported 1,549,364 shares, and TAL reported 171,273 shares. Collectively, these holdings represent a total of 3.21% of the company's common stock. The filing specifies that these shares were acquired in the ordinary course of business and not with the intention of changing or influencing the control of Altimmune. The filing was made in accordance with Rule 13d-1(b) of the Securities Exchange Act of 1934, which applies to certain institutional investment managers.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more